Vital Farms (VITL)
(Delayed Data from NSDQ)
$30.65 USD
-0.70 (-2.23%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $30.65 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$30.65 USD
-0.70 (-2.23%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $30.65 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Zacks News
TreeHouse Foods (THS) Q2 Earnings Beat Estimates, Sales Drop
by Zacks Equity Research
TreeHouse Foods' (THS) Q2 results reflect declines in sales and earnings on lower volumes. Management lowers the upper end of its adjusted EBITDA guidance for 2024.
Medifast (MED) Q2 Earnings Beat Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Medifast's (MED) Q2 results highlight the challenges of poor customer acquisition. However, the company is focusing strategically on medically supported weight loss, indicating potential for growth.
Zacks.com featured highlights include Vital Farms CSW Industrials, Atmos, NiSource and Kirby
by Zacks Equity Research
Vital Farms CSW Industrials, Atmos, NiSource and Kirby have been highlighted in this Screen of The Week article.
J&J Snack Foods (JJSF) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
J&J Snack Foods (JJSF) delivered earnings and revenue surprises of -1.49% and 0.40%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
5 Low-Leverage Stocks to Buy Amid Disappointing Job Data
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may buy VITL, CSWI, ATO, NI & KEX.
Inter Parfums (IPAR) Q2 Earnings in the Cards: Things to Note
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter performance is likely to reflect strong momentum in the fragrance market, supported by robust sales from its new licenses. High SG&A costs are a threat.
Monster Beverage's (MNST) Q2 Earnings Coming Up: Things to Note
by Zacks Equity Research
Monster Beverage's (MNST) second-quarter 2024 results are likely to reflect gains from strength in its energy drinks category and product launches.
B&G Foods' (BGS) Q2 Earnings in the Cards: Factors to Watch
by Zacks Equity Research
B&G Foods' (BGS) Q2 results are likely to reflect the impacts of category-wide challenges across the food industry and high SG&A costs.
Can Molson Coors' (TAP) Strategies Outrun Inflation Woes in Q2?
by Zacks Equity Research
Molson Coors' (TAP) strategic investments and premiumization efforts drive robust growth amid industry challenges and inflationary pressures. Let us see how the Q2 performance is likely to have been.
AB InBev (BUD) Tops on Q2 Earnings & Revenues on Robust Demand
by Zacks Equity Research
AB InBev's (BUD) Q2 results reflect strong consumer demand for its megabrands, double-digit organic EBITDA growth and continued optimization of its business.
Post Holdings (POST) Tops Q3 Earnings, Raises FY24 Outlook
by Zacks Equity Research
Post Holdings (POST) fiscal third-quarter results reflect sales growth in Post Consumer Brands and Weetabix, counterbalanced by declines in the Foodservice and Refrigerated Retail segments.
Implied Volatility Surging for Vital Farms (VITL) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Vital Farms (VITL) stock based on the movements in the options market lately.
Clorox (CLX) Q4 Earnings Beat Estimates, Gross Margin Expands
by Zacks Equity Research
Clorox's (CLX) fiscal 2025 gross margin is expected to improve by around 100 basis points, driven by comprehensive margin management efforts.
Mondelez (MDLZ) Q2 Earnings Beat, Organic Revenues Up 2.5%
by Zacks Equity Research
Mondelez (MDLZ) posts soft sales in second-quarter 2024, whereas organic revenues grow 2.5%. Strong pricing and cost management actions also fuel bottom-line growth.
Altria's (MO) Q2 Earnings Lag Estimates, Cigarette Volumes Drop
by Zacks Equity Research
Altria's (MO) second-quarter 2024 results reflect strong pricing, while cigarette shipment volumes remain soft. Management narrows the adjusted EPS view for 2024.
Clorox (CLX) Raises Dividend: What it Means for Investors
by Zacks Equity Research
Clorox's (CLX) strategy of incremental dividend growth not only bolsters shareholder income but also reinforces investor confidence in the company.
Diageo (DEO) FY24 Earnings & Sales Decline Y/Y on Soft Volume
by Zacks Equity Research
Diageo's (DEO) FY24 results reflect the impacts of soft volume particularly in LAC and North America, which hurt organic sales. Soft operating profit and higher costs hurt the bottom line.
Archer Daniels (ADM) Q2 Earnings & Revenues Miss, Down Y/Y
by Zacks Equity Research
Archer Daniels (ADM) reports lower revenues year over year in second-quarter 2024 owing to a decline in sales across its segments.
Procter & Gamble (PG) Q4 Earnings Beat, Stock Down on Sales Miss
by Zacks Equity Research
Procter & Gamble's (PG) Q4 earnings reflect gains from improved volume and pricing, offset by adverse currency rates and higher costs, which impact its operating margin.
Sysco (SYY) Shares Rise on Q4 Earnings Beat & Revenue Growth
by Zacks Equity Research
Sysco's (SYY) fourth-quarter fiscal 2024 results reflect improved earnings and revenues. The company witnesses positive operating leverage for the seventh consecutive time.
Sprouts Farmers (SFM) Gains as Q2 Earnings Beat & Comps Impress
by Zacks Equity Research
Sprouts Farmers (SFM) anticipates the gross margin to improve in the second half, in line with the first-half margin expansion.
Vital Farms (VITL) Rises Higher Than Market: Key Facts
by Zacks Equity Research
The latest trading day saw Vital Farms (VITL) settling at $36.82, representing a +1.94% change from its previous close.
Here's Why Vital Farms (VITL) is Poised for a Turnaround After Losing -22.77% in 4 Weeks
by Zacks Equity Research
Vital Farms (VITL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Newell's (NWL) Q2 Earnings Beat Mark, Soft Core Sales Hurt
by Zacks Equity Research
Newell (NWL) reports a sales decline in second-quarter 2024, owing to a core sales drop of 4.2% year over year.